人工肌腱和韧带市场规模、份额和成长分析（按植入类型、应用、最终用户和地区划分）—2026-2033年产业预测

全球人工肌腱和韧带市场规模预计在 2024 年达到 126.1 亿美元，从 2025 年的 143.2 亿美元增长到 2033 年的 397.3 亿美元，在预测期（2026-2033 年）内复合年增长率为 13.6%。

受微创手术需求不断增长以及人们对运动伤害的认识日益提高的推动，全球人工肌腱和韧带市场正经历显着增长。这些合成植入的研发关键在于性能、设计、材料选择以及透过临床前和临床试验进行的全面评估，重点在于机械负荷和疲劳测试。传统植入手术的併发症，例如断裂和膝关节不适，促使人们对合成替代方案产生了浓厚的兴趣。持续的研发工作旨在创造兼具高抗拉强度和组织相容性的创新材料。尤其是在生物工程领域，一些前景广阔的进展有望改善植入的功能和生物整合性，从而进一步推动市场成长，因为相关人员正在寻求用于有效韧带修復的更优材料。

全球人工肌腱和韧带市场驱动因素

推动全球人工肌腱和韧带市场发展的关键因素之一是运动伤害发生率的不断上升。这些损伤通常由多种因素引起，包括意外事故、技术不当、热身和拉伸不足以及体能训练不足。运动员会经历各种各样的损伤，例如网球肘、踝关节扭伤、鼠蹊部拉伤、腘绳肌拉伤和前十字韧带 (ACL)断裂。人们对这些损伤的认识不断提高，对有效治疗方法的需求日益增长，推动了市场的发展，个人和医疗保健机构都在寻求创新的解决方案来应对这些挑战。

全球人工肌腱和韧带市场阻碍因素

研发成本的不断攀升预计将阻碍全球人工肌腱和韧带市场的成长。此外，该市场在不久的将来可能面临安全性和合规性方面的挑战。这些因素可能成为该领域企业发展的障碍，阻碍创新和新产品上市。为了应对这种复杂的市场环境，企业可能需要投入大量资源来确保安全标准并遵守监管要求，最终可能会影响其整体市场表现和扩张潜力。

全球人工肌腱和韧带市场趋势

全球人工肌腱和韧带市场正呈现显着的膝关节损伤治疗趋势，这主要受运动参与度提高以及膝关节损伤发生率上升的推动。由于人工修復具有恢復时间短、可得性等诸多优势，患者越来越倾向于选择人工修復方案而非传统的异体移植手术。人工韧带手术效率更高，例如手术时间比自体移植更短，这进一步提升了其吸引力。随着医疗技术的进步和意识提升，预计该细分市场对膝关节损伤治疗创新解决方案的需求将进一步增强。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管环境
• 案例研究
• 技术进步

全球人工肌腱和韧带市场规模（植入类型和复合年增长率划分）（2026-2033 年）

• 硅胶棒植入
• Marlex 网
• 碳纤维植入
• 其他的

全球人工肌腱和韧带市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 膝伤
• 肩部受伤
• 足部和踝部损伤
• 脊髓损伤
• 髋关节损伤
• 其他的

全球人工肌腱和韧带市场规模（按最终用户划分）及复合年增长率（2026-2033 年）

• 医院
• 专科诊所
• 门诊手术中心
• 其他的

全球人工肌腱和韧带市场规模（按地区划分）及复合年增长率（2026-2033 年）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Smith+Nephew（United Kingdom）
• Zimmer Biomet（United States）
• Xiros Ltd.（Neoligaments）（United Kingdom）
• Orthomed SAS（France）
• Shanghai PINE&POWER Biotech（China）
• Arthrex Inc.（United States）
• Corin Group（United Kingdom）
• Enovis Corporation（Mathys AG Bettlach）（Switzerland）
• Stryker Corporation（United States）
• GROUP FH ORTHO（France）
• FX Solutions（France）
• LARS（Corin Group）（France）
• Cousin Biotech（France）
• Mathys AG Bettlach（Switzerland）
• Ossur hf（Iceland）
• Integra LifeSciences Holdings Corporation（United States）
• Medtronic plc（Ireland）
• Orthonika, Inc.（United Kingdom）
• United Orthopedic Corporation（Taiwan）

结论与建议

Global Artificial Tendons And Ligaments Market size was valued at USD 12.61 Billion in 2024 and is poised to grow from USD 14.32 Billion in 2025 to USD 39.73 Billion by 2033, growing at a CAGR of 13.6% during the forecast period (2026-2033).

The global market for artificial tendons and ligaments is experiencing significant growth driven by rising demand for minimally invasive surgical procedures and increased awareness of sports-related injuries. Key considerations in the development of these synthetic implants include performance, design, material selection, and thorough evaluation through pre-clinical and clinical studies, focusing on mechanical loads and fatigue testing. Complications from traditional graft surgeries, such as tendon rupture and knee discomfort, have amplified interest in synthetic alternatives. Ongoing R&D efforts aim to produce innovative materials that exhibit high tensile strength and compatibility with natural tissues. Promising advancements, particularly in bioengineering, are poised to enhance implant functionality and integration, further propelling market growth as stakeholders explore superior materials for effective ligament restoration.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Artificial Tendons And Ligaments market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Artificial Tendons And Ligaments Market Segments Analysis

Global Artificial Tendons And Ligaments Market is segmented by Implant Type, Application, End User and region. Based on Implant Type, the market is segmented into Silastic-rod implant, Marlex mesh, Carbon-Fibre implant and Others. Based on Application, the market is segmented into Knee Injuries, Shoulder Injuries, Foot & Ankle Injuries, Spine Injuries, Hip Injuries and Others. Based on End User, the market is segmented into Hospitals, Specialty Clinics, Ambulatory Surgery Centres and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Artificial Tendons And Ligaments Market

A significant factor driving the Global Artificial Tendons and Ligaments market is the increasing incidence of sports injuries. These injuries often result from various factors including accidents, improper techniques, insufficient warm-up and stretching practices, as well as inadequate physical conditioning. Athletes commonly experience a range of these injuries, including conditions such as tennis elbow, ankle sprains, groin pulls, hamstring strains, and tears of the anterior cruciate ligament (ACL). The growing awareness of these injuries and the associated demand for effective treatment options are propelling the market forward, as individuals and healthcare providers seek innovative solutions to address these challenges.

Restraints in the Global Artificial Tendons And Ligaments Market

Increasing expenses associated with research and development are anticipated to hinder the growth of the Global Artificial Tendons and Ligaments market. Additionally, the market is likely to encounter challenges related to safety and regulatory compliance in the near future. These factors may create obstacles for companies operating within this sector, complicating their capacity to innovate and bring new products to market. As organizations navigate these complexities, they may need to allocate significant resources toward ensuring safety standards and meeting regulatory requirements, which could ultimately impact their overall market performance and expansion potential.

Market Trends of the Global Artificial Tendons And Ligaments Market

The Global Artificial Tendons and Ligaments market showcases a significant trend towards the knee injuries segment, driven by increasing sports participation and the corresponding rise in knee injury incidences. Patients tend to prefer artificial solutions over traditional surgical treatments using allografts due to various advantages such as reduced recovery times and improved availability. The operational efficiency associated with artificial ligaments, including quicker procedure times compared to donor grafts, further bolsters their appeal. As healthcare technologies advance and patient awareness grows, the demand for innovative solutions in managing knee injuries is expected to strengthen within this market segment.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Artificial Tendons And Ligaments Market Size by Implant Type & CAGR (2026-2033)

• Market Overview
• Silastic-rod implant
• Marlex mesh
• Carbon-Fibre implant
• Others

Global Artificial Tendons And Ligaments Market Size by Application & CAGR (2026-2033)

• Market Overview
• Knee Injuries
• Shoulder Injuries
• Foot & Ankle Injuries
• Spine Injuries
• Hip Injuries
• Others

Global Artificial Tendons And Ligaments Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Specialty Clinics
• Ambulatory Surgery Centres
• Others

Global Artificial Tendons And Ligaments Market Size & CAGR (2026-2033)

• North America (Implant Type, Application, End User)
  • US
  • Canada
• Europe (Implant Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Implant Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Implant Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Implant Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Smith+Nephew (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xiros Ltd. (Neoligaments) (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orthomed S.A.S. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai PINE&POWER Biotech (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arthrex Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corin Group (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enovis Corporation (Mathys AG Bettlach) (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GROUP FH ORTHO (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FX Solutions (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LARS (Corin Group) (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cousin Biotech (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mathys AG Bettlach (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ossur hf (Iceland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Holdings Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orthonika, Inc. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• United Orthopedic Corporation (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations